The Met tyrosine kinase receptor in development and cancer
- 4 January 2008
- journal article
- review article
- Published by Springer Science and Business Media LLC in Cancer and Metastasis Reviews
- Vol. 27 (1), 85-94
- https://doi.org/10.1007/s10555-007-9107-6
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 SignalingScience, 2007
- c-Met is essential for wound healing in the skinThe Journal of cell biology, 2007
- Validation of Met as a Therapeutic Target in Alveolar and Embryonal RhabdomyosarcomaCancer Research, 2006
- Hepatocyte Growth Factor Receptor Tyrosine Kinase Met Is a Substrate of the Receptor Protein-tyrosine Phosphatase DEP-1Published by Elsevier BV ,2003
- Scatter-factor and semaphorin receptors: cell signalling for invasive growthNature Reviews Cancer, 2002
- Coupling Met to Specific Pathways Results in Distinct Developmental OutcomesMolecular Cell, 2001
- Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomasOncogene, 2000
- Ets transcription factors cooperate with Sp1 to activate the human Tenascin-C promoterOncogene, 1999
- Hepatocyte Growth Factor-induced Scatter of Madin-Darby Canine Kidney Cells Requires Phosphatidylinositol 3-KinasePublished by Elsevier BV ,1995
- Scatter factor is a fibroblast-derived modulator of epithelial cell mobilityNature, 1987